[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100203103":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":7,"locations":7,"responsibleParty":12,"collaborators":7,"id":14,"slug":15,"hasResults":16,"nctId":17,"briefTitle":18,"officialTitle":18,"acronym":19,"eligibilityCriteria":20,"healthyVolunteers":16,"sex":21,"minAge":7,"maxAge":22,"enrollmentInfo":23,"targetDuration":7,"studyType":26,"phases":7,"briefSummary":27,"conditions":28,"keywords":7,"overallStatus":30,"whyStopped":7,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":7},{"fullName":5,"class":6},"GlaxoSmithKline","INDUSTRY",null,[9],{"name":10,"affiliation":5,"role":11},"GSK Clinical Trials","STUDY_DIRECTOR",{"type":13,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100203103","place-of-flixovate-in-the-treatment-pathway-and-its-conditions-of-use-in-infants-aged-from-3-to-12-months-between-2010-and-2012-by-french-gps-and-private-paediatricians-100203103",false,"NCT01920464","Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private Paediatricians","flixovate HAS","Inclusion Criteria:\n\nAnalysis of changes in share of prescriptions:\n\n* Infants who received at least one prescription of topical steroids between 1st January 2010 and 31st December 2012.\n* Infants aged 3 to 12 months on the day of prescription of topical steroids.\n\nDescription of the conditions of use and patient profiles:\n\n* Infants who received at least one prescription of topical steroids between 1st January 2010 and 31st December 2012.\n* Infants aged 3 to 12 months on the day of prescription of topical steroids.\n\nExclusion Criteria:\n\n* none","ALL","12 Months",{"count":24,"type":25},160,"ACTUAL","OBSERVATIONAL","this study has been request by french health authorities to evaluate the use of flixovate in infants and its place in the treatment pathway.\n\nthis study has 2 main pbjectives: 1\u002F Evaluation of changes in the prescription share of Flixovate® compared to other topical corticosteroids (low, medium and high potency) in the population of infants aged from 3 to 12 months, from 1st January 2010 to 31st December 2012. 2\u002FDescription of the conditions of use of Flixovate® in infants aged less than 12 months (infant profile, dosage form, dosage, treatment duration, prior, concomitant and subsequent treatments etc.).",[29],"Dermatitis, Atopic","COMPLETED","2014-09-11",{"date":33,"type":34},"2014-09-15","ESTIMATED",{"date":36,"type":7},"2013-04",{"date":38,"type":25},"2013-10",{"name":5,"class":6}]